Home > Boards > US Listed > Medical - Drugs > Allergan (AGN)

Why is this board not connected to the ticker??

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
T695 Member Profile
 
Followed By 49
Posts 3,581
Boards Moderated 0
Alias Born 05/18/14
160x600 placeholder
Allergan to Report Third Quarter 2019 Financial Results PR Newswire (US) - 10/17/2019 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/15/2019 6:35:12 AM
Allergan Shareholders Approve Proposed Acquisition by AbbVie PR Newswire (US) - 10/14/2019 9:15:00 AM
Allergan and Molecular Partners Present Late-Breaking Data from Phase 3 Studies of Investigational Abicipar pegol in Neovascu... PR Newswire (US) - 10/11/2019 7:40:00 PM
On World Sight Day, Allergan Launches National Campaign to Raise Awareness of the Toll Glaucoma Takes on Everyday Living PR Newswire (US) - 10/10/2019 7:30:00 AM
Allergan Expands REFRESH® Portfolio With New REFRESH® RELIEVA™ Lubricant Eye Drop Product Line PR Newswire (US) - 10/7/2019 7:30:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 10/3/2019 4:11:56 PM
Allergan to Showcase Late-Stage Data in Age-Related Macular Degeneration and Glaucoma at American Academy of Ophthalmology An... PR Newswire (US) - 10/3/2019 7:30:00 AM
Drugmakers Look to Use Purdue Pharma's Bankruptcy to Settle Opioid Suits Dow Jones News - 9/30/2019 5:41:00 PM
FTC Requests for More Information From AbbVie-Allergan Tie-Up Dow Jones News - 9/27/2019 5:38:00 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 9/27/2019 4:51:03 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/27/2019 4:46:54 PM
Allergan and AbbVie Receive Second Request from Federal Trade Commission on Pending Transaction PR Newswire (US) - 9/27/2019 4:16:00 PM
AbbVie and Allergan Receive Second Request from Federal Trade Commission on Pending Transaction PR Newswire (US) - 9/27/2019 4:15:00 PM
Announcement under the Irish Takeover Rules: Relevant Securities in Issue - September 17, 2019 PR Newswire (US) - 9/17/2019 4:15:00 PM
Allergan Announces Commencement of Mailing of Proxy Statement PR Newswire (US) - 9/17/2019 7:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/16/2019 4:17:54 PM
Proxy Statement - Merger or Acquistion (definitive) (defm14a) Edgar (US Regulatory) - 9/16/2019 4:02:54 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/11/2019 6:36:11 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 9/11/2019 6:35:28 AM
Allergan Shareholder Meetings Scheduled for October 14, 2019 PR Newswire (US) - 9/10/2019 4:36:00 PM
Allergan and Molecular Partners Announce Acceptance of U.S. FDA Biologics License Application and Validation of EMA Marketing... PR Newswire (US) - 9/9/2019 7:30:00 AM
Allergan Receives FDA Approval of Juvéderm VOLUMA® XC For Mid-Face Injection Via Cannula PR Newswire (US) - 9/3/2019 7:30:00 AM
Allergan Announces Settlement with Two Ohio Plaintiffs in Federal Opioid Litigation PR Newswire (US) - 8/30/2019 7:00:00 AM
Amgen And Allergan Announce Positive Top-Line Results From Comparative Clinical Study Of ABP 798, Biosimilar Candidate To Rit... PR Newswire (US) - 8/22/2019 9:00:00 AM
T695   Monday, 11/06/17 10:47:08 AM
Re: DewDiligence post# 143
Post # of 195 
Why is this board not connected to the ticker??

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist